Once-Monthly Long-Acting Injectable Aripiprazole for the Treatment of Patients with Schizophrenia and Co-occurring Substance Use Disorders: A Multicentre, Observational Study

  1. Szerman, N.
  2. Basurte-Villamor, I.
  3. Vega, P.
  4. Martinez-Raga, J.
  5. Parro-Torres, C.
  6. Cambra Almerge, J.
  7. Grau-López, L.
  8. De Matteis, M.
  9. Arias, F.
Journal:
Drugs - Real World Outcomes

ISSN: 2198-9788,  2199-1154

Year of publication: 2020

Volume: 7

Issue: 1

Pages: 75-83

Type: Article

DOI: 10.1007/S40801-020-00178-8 GOOGLE SCHOLAR lock_openOpen access editor
Data source: Scopus